Consistent with these observations, our research demonstrated that Di-ART-GPC improved lung pathology in BPD mice, particularly by reducing fibrosis levels and decreasing TGF-β1 and α-SMA levels. Here, ACTA1 is linked to bronchopulmonary dysplasia.